Société d'Exploration et de Traitements Endocriniens et Gynécologiques
0438.767.721 · rovalta.com · 28/09/2026
ACTIVE
Société d'Exploration et de Traitements Endocriniens et Gynécologiques
Financial year 2025 · Closed on 31/12/2025
Net result14,7 k €+18,7 %over 1 year
Gross margin79,5 k €-0,1 %over 1 year
Equity779,8 k €+1,9 %over 1 year
Overview
Identity
Source · BCE/KBOSociété d'Exploration et de Traitements Endocriniens et Gynécologiques is a Private limited company incorporated in 1989. Its registered office is in Ans.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0438.767.721
- Incorporation
- 02/11/1989
- Legal form
- Private limited company
- Registered office
- Rue Edouard Colson 59
4431 Ans · WallonieSee on map - Contributed capital
- 6 197,33 €
- Latest accounts
- 31/12/2025
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 79,5 k € | -0.1% | 79,6 k € | -26.6% | 108,6 k € | -26.1% | 147 k € | -67.3% | 449,8 k € |
| EBITDA | 68,9 k € | -4.0% | 71,8 k € | -28.4% | 100,2 k € | -20.3% | 125,7 k € | -70.5% | 425,6 k € |
| Operating result | 24,2 k € | +16.5% | 20,8 k € | -56.7% | 48 k € | -35.3% | 74,3 k € | -81.2% | 395,4 k € |
| Net result | 14,7 k € | +18.7% | 12,4 k € | -57.7% | 29,3 k € | -38.4% | 47,5 k € | -81.6% | 257,7 k € |
| Balance sheet | |||||||||
| Equity | 779,8 k € | +1.9% | 765,1 k € | +1.6% | 752,7 k € | +4.0% | 723,5 k € | +7.0% | 676 k € |
| Total assets | 1,1 M € | -2.5% | 1,1 M € | -3.8% | 1,2 M € | -1.8% | 1,2 M € | -18.3% | 1,5 M € |
| Cash | 20,5 k € | -1.6% | 20,9 k € | +17.1% | 17,8 k € | +143% | 7,3 k € | -75.4% | 29,8 k € |
| Debts | 311,9 k € | -12.3% | 355,6 k € | -12.1% | 404,4 k € | -11.4% | 456,3 k € | -41.0% | 773 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean-Paul Renwart | Director30/06/2014 → 30/06/2029Manager30/06/2007 → 30/06/2029ended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/05/2026 | 10/06/2025 | 26/05/2024 | 20/06/2023 | 21/05/2022 | 25/07/2021 |
| General meeting | 22/05/2026 | 06/06/2025 | 23/05/2024 | 15/06/2023 | 09/05/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 22/05/2026 | 25/05/2026 | French | |
| Micro model | 31/12/2024 | 06/06/2025 | 10/06/2025 | French | |
| Micro model | 31/12/2023 | 23/05/2024 | 26/05/2024 | French | |
| Micro model | 31/12/2022 | 15/06/2023 | 20/06/2023 | French | |
| Micro model | 31/12/2021 | 09/05/2022 | 21/05/2022 | French | |
| Micro model | 31/12/2020 | 30/06/2021 | 25/07/2021 | French | |
| Micro model | 31/12/2019 | 10/09/2020 | 21/09/2020 | French | |
| Micro model | 31/12/2018 | 08/05/2019 | 11/05/2019 | French | |
| Micro model | 31/12/2017 | 29/06/2018 | 31/07/2018 | French | |
| Micro model | 31/12/2016 | 30/06/2017 | 30/08/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 15/06/2015 | 18/06/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 08/08/2014 | French | |
| Abridged model | 31/12/2012 | 28/06/2013 | 10/07/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 30/08/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 17/08/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 30/08/2010 | French | |
| Abridged model | 31/12/2008 | 30/06/2009 | 31/07/2009 | French | |
| Abridged model | 31/12/2007 | 30/06/2008 | 05/08/2008 | French | |
| Abridged model | 31/12/2006 | 29/06/2007 | 30/08/2007 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean-Paul Renwart | Director30/06/2014 → 30/06/2029Manager30/06/2007 → 30/06/2029ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates23/07/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
- Other04/12/2017STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates26/08/2014DEMISSIONS, NOMINATIONS
- Mandates09/10/2007DEMISSIONS, NOMINATIONS
- Mandates10/11/2005DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings20 filings
Mandates
Jean-Paul Renwart
19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
ETEG
Rue Edouard Colson 59, 4431 Loncin
DirectorManager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue Edouard Colson 59, 4431 LoncinCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00119395 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Société d'Exploration et de Traitements Endocriniens et GynécologiquesCurrent | CBE | |
| ETEG | accounts 2021 → 2025 | Accounts 2025 · 2026-00119395 |
Events
- 2025Annual accounts 202514,7 k €↑
- 2024Annual accounts 202412,4 k €↓
- 2023Annual accounts 202329,3 k €↓
- 2022Annual accounts 202247,5 k €↓
- 2021Annual accounts 2021257,7 k €↑
- 2020Annual accounts 202060,6 k €↓
- 2019Annual accounts 201960,7 k €↑
- 2018Annual accounts 201842,3 k €↑
- 2017Annual accounts 201717,1 k €↓
- 2016Annual accounts 201631,2 k €↓
- 2015Annual accounts 201570,5 k €↓
- 2014Annual accounts 201471,9 k €↑
- 2013Annual accounts 2013-35,4 k €↓
- 2012Annual accounts 2012-34,2 k €↑
- 2011Annual accounts 2011-67,8 k €↓
- 2010Annual accounts 2010-41,9 k €↓
- 2009Annual accounts 200932,8 k €↑
- 2008Annual accounts 200830,5 k €↓
- 2007Annual accounts 200740,5 k €↑
- 2006Annual accounts 200635,2 k €
- 02/11/1989IncorporationPrivate limited company